BeOne Medicines AG (HKG:6160)
Hong Kong · Delayed Price · Currency is HKD 163.70
+6.30 (4.00%)
Jun 18, 2026, 4:08 PM HKT
BeOne Medicines AG Market Cap
BeOne Medicines AG has a market cap or net worth of 235.39 billion as of June 18, 2026. Its market cap has increased by 5.73% in one year.
Market Cap
235.39B
Enterprise Value
206.73B
Revenue
44.73B
Ranking
n/a
PE Ratio
56.25
Stock Price
163.70
Market Cap Chart
Since February 3, 2016, BeOne Medicines AG's market cap has increased from 6.70B to 235.39B, an increase of 3,414.95%. That is a compound annual growth rate of 40.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 235.39B | -10.04% |
| Dec 31, 2025 | 261.67B | 71.29% |
| Dec 31, 2024 | 152.77B | 4.09% |
| Dec 29, 2023 | 146.76B | -17.60% |
| Dec 30, 2022 | 178.11B | -17.96% |
| Dec 31, 2021 | 217.12B | 19.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innovent Biologics | 132.37B |
| WuXi Biologics | 127.40B |
| Sichuan Kelun-Biotech Biopharmaceutical | 94.07B |
| Sino Biopharmaceutical | 81.66B |
| Akeso | 80.65B |
| RemeGen | 61.20B |
| Biocytogen Pharmaceuticals (Beijing) | 41.22B |
| 3SBio | 40.59B |